Integrin antagonists

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/64 (2006.01) A61K 38/16 (2006.01) A61P 17/02 (2006.01) A61P 27/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 14/705 (2006.01) C12N 15/57 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2400040

The present invention provides methods and compositions for inhibiting the biological activity of integrins, for inhibiting endothelial cell migration, and for inhibiting angiogenesis. In particular, the invention provides compositions comprising ADAM disintegrin domains and methods for using said compositions. In preferred embodiments the methods and compositions of the invention are used to inhibit angiogenesis and to treat diseases or conditions mediated by angiogenesis.

La présente invention concerne des méthodes et des compositions permettant d'inhiber l'activité biologique des intégrines, la migration des cellules endothéliales et l'angiogénèse. L'invention concerne plus particulièrement des compositions contenant des domaines désintégrine ADAM ainsi que des procédés d'utilisation de ces compositions. Dans des modes de réalisation préférés, on utilise les méthodes et les compositions de l'invention afin d'inhiber l'angiogénèse et de traiter les maladies ou les états pathologiques induits par l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Integrin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1793293

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.